Buprenorphine treatment for opioid use disorder in non–addiction specialty settings.

JAMA Network Open logoThis cohort study, partially supported by the CTN Greater Intermountain Node, evaluates changes in prescribing of buprenorphine treatment for opioid use disorder at primary care, mental health, and pain clinics and substance use disorder clinics in Stepped Care for Opioid Use Disorder Train the Trainer (SCOUTT) and non-SCOUTT facilities.

Categories: Buprenorphine, CTN platform/ancillary study, Opioid use disorder, Pharmacological therapy, Primary care
Tags: Article (Peer-Reviewed)
Authors: Huebler, Sophia; Jones, Audrey L.; Zhao, Hongwei; Nelson, Richard E.; Hagedorn, Hildi J.; Hawkins, Eric J.; Gordon, Adam J.
PMCID: PMC12616456
PMID: 41231472
Source: JAMA Network Open 2025;8(11):e2543543. [doi: 10.1001/jamanetworkopen.2025.43543]